6 ADVERSE REACTIONS
The following adverse reactions are discussed elsewhere in labeling:
- Hypertension [see Warnings and Precautions (5.1)]
- Pulmonary Edema [see Warnings and Precautions (5.2)]
- Cardiac Arrhythmias and Ischemia [see Warnings and Precautions (5.3)]
- Extravasation and Tissue Necrosis with Intravenous Infusion [see Warnings and Precautions (5.4)]
- Renal Impairment [see Warnings and Precautions (5.5)]
- Allergic Reactions associated with Sulfite [see Warnings and Precautions (5.6)]
The following adverse reactions have been associated with use of epinephrine. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to estimate their frequency reliably or to establish a causal relationship to drug exposure.
Cardiovascular disorders: tachycardia, supraventricular tachycardia, ventricular arrhythmias (including fatal ventricular fibrillation), myocardial ischemia, myocardial infarction, limb ischemia, pulmonary edema, hypertension
Gastrointestinal disorders: nausea, vomiting
General disorders and administrative site conditions: extravasation
Metabolic: insulin resistance, hypokalemia, lactic acidosis
Nervous system disorders: headache, paresthesia, tremor, stroke, central nervous system bleeding, weakness, dizziness, disorientation, impaired memory, panic, psychomotor agitation, somnolence
Psychiatric disorders: excitability, anxiety, apprehensiveness, nervousness, restlessness
Renal disorders: renal insufficiency
Respiratory: rales
Skin and subcutaneous tissue disorders: diaphoresis, pallor, piloerection, skin blanching, skin necrosis with extravasation.